'Game Changing' Apitope Plans IPO To Progress First-In-Class MS Drug

 
• By Sten Stovall
  
IPO
Apitope To IPO On EuroNext Brussels For Progressing Autoimmune Therapies • Source: Shutterstock

More from Financing

More from Business